Atopy Patch Test in Normal Population : Pilot Study
1 other identifier
interventional
15
1 country
1
Brief Summary
Atopy patch test in normal population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Feb 2010
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 16, 2010
CompletedFirst Posted
Study publicly available on registry
July 2, 2010
CompletedJuly 2, 2010
July 1, 2010
3 months
May 16, 2010
July 1, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reaction of atopy patch test
To evaluate outcome of atopy patch test reaction in non-atopic subject
3 days
Secondary Outcomes (1)
Comparisons atopy patch test reaction between lyophilized allergen and commercial allergen
3 days
Study Arms (1)
Atopy patch test
EXPERIMENTALAtopy patches were applied on healthy volunteer's back for 48 hrs then the patches were removed. Reaction was evaluated 48 and 72 hrs after applying atopy patch test
Interventions
Atopy patches used with food lyophilized allergen and commercial allergen were placed on back of subjects for 48 hrs then atopy patches were taken off. Subjects should return to evaluate reaction one day later(72 hrs after applying atopy patch test)
Eligibility Criteria
You may qualify if:
- Healthy volunteer
- Age 18-40 yrs
- Volunteer sign for informed consent
You may not qualify if:
- who have dermographism
- who have chronic disease eg.autoimmune disease, immune deficiency, cancer or allergic disease
- pregnant women
- who have severe eczema
- who receive antihistamine, topical steroid and systemic steroid \> 20 mg/day within 7 days prior study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics, Siriraj hospital, Mahidol University
Bangkok, 10700, Thailand
Study Officials
- STUDY DIRECTOR
Nualanong Visitsunthorn, Professor
Mahidol University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 16, 2010
First Posted
July 2, 2010
Study Start
February 1, 2010
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
July 2, 2010
Record last verified: 2010-07